• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

The Obesity Drug Pipeline: 10 Questions on Rx Development

Slideshow

Take this quick quiz to test your knowledge of recent advances most likely to have an impact on weight management in your practice.

Treatments for patients with obesity are in development across the pharmaceutical industry, including molecules with novel mechanisms of action that have been evaluated in clinical trials but have not yet received FDA approval.

Take this quick quiz to test your knowledge of the recent advances most likely to have an impact on weight management in your practice.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
Related Content
FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions

FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions

Grace Halsey
October 23rd 2024
Article

Pfizer announced the FDA approval on October 22 that makes Abrysvo now the RSV immunization with the broadest indication for adults, the company said.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

FDA Grants Priority Review to GSK NDA for First-In-Class Oral Antibiotic / Image credit: ©sopradit/AdobeStock

FDA Grants Priority Review to GSK NDA for First-In-Class Oral Antibiotic

Sydney Jennings
October 16th 2024
Article

The FDA today accepted GSK's NDA for gepotidacin for the treatment of uncomplicated urinary tract infections in women and adolescents.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

GLP-1RAs May Lower Risk of Suicidal Ideation for Youth with Obesity, New Data Suggest / Image credit: ©Natalia/AdobeStock

GLP-1RAs May Lower Risk of Suicidal Ideation for Youth with Obesity, New Data Suggest

Sydney Jennings
October 15th 2024
Article

In a study of adolescents with obesity, those in the GLP-1RA group had a 33% lower risk of experiencing suicidal ideation or attempts compared with matched controls.

FDA Faces Law Suit Over Sudden Removal of Tirzepatide from Drug Shortage List / image credit Mounjaro: ©MK Photo/stock.adobe.com

FDA Faces Law Suit Over Sudden Removal of Tirzepatide from Drug Shortage List

Ashley Gallagher;Grace Halsey
October 15th 2024
Article

Update: The FDA has told compounding pharmacies they may resume production of tirzepatide products while the agency further investigates supply.

© 2024 MJH Life Sciences

All rights reserved.